News Headlines Article

Publication bias, not conflicts, may be bigger concern in cancer trial reports
Modern Healthcare

A new study of conflicts of interest in leading cancer journals’ reports about phase 3 clinical trials showed financial connections between the study authors or editorialists and the companies that either sponsored the trials or had a stake in their outcome had little impact on interpretation of the results.

However, the study did identify confounding factors—the greatest being the bias to publish positive results in a field that is generally marked by a high level of failure.